Purdue University-Main Campus · BiologyVaccine Innovation Hub
Suresh K Mittal · West Lafayette, Indiana
Research Focus
Dr. Suresh K Mittal's lab at Purdue University focuses on developing innovative vaccines, particularly for COVID-19 and influenza. They aim to create a new adenoviral vaccine platform that is effective even in vulnerable populations, such as the elderly. The research also explores antibody-dependent enhancement and the immune response to these vaccines, which could contribute significantly to public health initiatives against pandemics.
COVID-19vaccine developmentadenoviral vectorimmunogenicityantibody response
Research Aims
5AIM 01Evaluate the immunogenicity of a novel adenoviral vaccine platform for COVID-19.
AIM 02Investigate the antibody-dependent enhancement of SARS-CoV-2 infection.
AIM 03Assess the quality of memory B and T cell responses post-immunization.
AIM 04Determine the durability of protective immunity in animal models.
AIM 05Develop a novel antigen design that enhances immune response.
Skills the Lab Values
animal modelsvaccine formulationimmunological assaysantibody analysispeptide synthesis
Output against the department
Publications132bottom 47% of dept.546th of 1,033
this lab
most publishedleast published
Citations5.3kbottom 40% of dept.622nd of 1,033
this lab
most citedleast cited
Career totals from OpenAlex, compared against labs that share a department. A department spans everything from one paper to tens of thousands, so bar heights are on a log scale — otherwise the largest lab would flatten every other bar to a line.